Position in HLN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,186,244
-$991,636 QoQ
Shares Held
127,143
-47.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#131
of 639 holders
Holding Since
Sep 2022
7 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Squarepoint Ops LLC holds $151,394,819 across 40 Drug Manufacturers - Specialty & Generic names. HLN ranks #21 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
633,370 | $45,513,968 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
48,656 | $26,363,280 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
|
617,308 | $21,402,068 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
140,059 | $8,956,773 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
44,143 | $7,439,861 | |
| 6 | ALKS |
Alkermes plc.
|
115,195 | $6,036,218 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
133,225 | $3,278,667 | |
| 8 | HROW |
Harrow, Inc.
|
73,622 | $3,126,726 |
All Filings in HLN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,186,244 | 127,143 | Shares | Defined | 2026-08-14 | |
| 2025-09-30 | $2,177,880 | 242,796 | Shares | Defined | 2025-11-14 | |
| 2025-03-31 | $1,675,808 | 162,858 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $655,314 | 61,939 | Shares | Defined | 2024-11-14 | |
| 2023-12-31 | $1,412,539 | 171,633 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $356,723 | 42,824 | Shares | Defined | 2023-11-14 | |
| 2022-09-30 | $151,781 | 24,923 | Shares | Defined | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||